icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Barcelona, Spain
13-17 April 2016
Back grey_arrow_rt.gif
 
 
 
High Efficacy of Sofosbuvir/Velpatasvir/GS-9857 With or Without Ribavirin for 12 Weeks in Direct-Acting Antiviral-Experienced Patients With Genotype 1 HCV Infection
 
 
  from Jules: these are patients with prior DAA experience: NS5A, protease, NS5B...48/49 had SVR....1 relapse
 
Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
 
Eric Lawitz1, Fred Poordad1, Jennifer Wells1, Robert H. Hyland2, Yin Yang2, Hadas Dvory-Sobol2, Luisa M. Stamm2, Diana M. Brainard2,
John G. McHutchison2, Carmen Landaverde1, Julio Gutierrez1
1Texas Liver Institute, University of Texas Health Science Center, San Antonio, Texas, USA; 2Gilead Sciences, Inc., Foster City, California, USA

CROI1

CROI2

CROI3

CROI4

CROI5

CROI6

CROI7

CROI8